21-34512227-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000684114.1(ENSG00000288711):n.488-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 152,182 control chromosomes in the GnomAD database, including 4,814 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 4813 hom., cov: 32)
Exomes 𝑓: 0.16 ( 1 hom. )
Consequence
ENSG00000288711
ENST00000684114.1 intron
ENST00000684114.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0500
Genes affected
KCNE1 (HGNC:6240): (potassium voltage-gated channel subfamily E regulatory subunit 1) The product of this gene belongs to the potassium channel KCNE family. Potassium ion channels are essential to many cellular functions and show a high degree of diversity, varying in their electrophysiologic and pharmacologic properties. This gene encodes a transmembrane protein known to associate with the product of the KVLQT1 gene to form the delayed rectifier potassium channel. Mutation in this gene are associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 21-34512227-G-A is Benign according to our data. Variant chr21-34512227-G-A is described in ClinVar as [Benign]. Clinvar id is 339790.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-34512227-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.501 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
use as main transcript | n.34512227G>A | intergenic_region | ||||||
KCNE1 | NM_000219.6 | c.-577C>T | upstream_gene_variant | ENST00000399286.3 | NP_000210.2 | |||
KCNE1 | XM_047440764.1 | c.-540C>T | upstream_gene_variant | XP_047296720.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000288711 | ENST00000684114.1 | n.488-9C>T | intron_variant | ENSP00000507841.1 | ||||||
KCNE1 | ENST00000399286.3 | c.-577C>T | upstream_gene_variant | 1 | NM_000219.6 | ENSP00000382226.2 |
Frequencies
GnomAD3 genomes AF: 0.235 AC: 35737AN: 152032Hom.: 4811 Cov.: 32
GnomAD3 genomes
AF:
AC:
35737
AN:
152032
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.156 AC: 5AN: 32Hom.: 1 Cov.: 0 AF XY: 0.167 AC XY: 5AN XY: 30
GnomAD4 exome
AF:
AC:
5
AN:
32
Hom.:
Cov.:
0
AF XY:
AC XY:
5
AN XY:
30
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.235 AC: 35742AN: 152150Hom.: 4813 Cov.: 32 AF XY: 0.238 AC XY: 17695AN XY: 74386
GnomAD4 genome
AF:
AC:
35742
AN:
152150
Hom.:
Cov.:
32
AF XY:
AC XY:
17695
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1158
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Congenital long QT syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Long QT syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Jervell and Lange-Nielsen syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at